Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Total Non-Current Liabilities (2021 - 2025)

Zymeworks' Total Non-Current Liabilities history spans 3 years, with the latest figure at $130.2 million for Q3 2023.

  • For Q3 2023, Total Non-Current Liabilities rose 8.76% year-over-year to $130.2 million; the TTM value through Sep 2023 reached $130.2 million, up 8.76%, while the annual FY2022 figure was $152.7 million, 11.2% up from the prior year.
  • Total Non-Current Liabilities for Q3 2023 was $130.2 million at Zymeworks, down from $149.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $152.7 million in Q4 2022 and bottomed at $119.7 million in Q3 2022.
  • The 3-year median for Total Non-Current Liabilities is $133.7 million (2021), against an average of $135.8 million.
  • The largest annual shift saw Total Non-Current Liabilities increased 11.2% in 2022 before it grew 8.76% in 2023.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $137.3 million in 2021, then grew by 11.2% to $152.7 million in 2022, then decreased by 14.74% to $130.2 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Total Non-Current Liabilities are $130.2 million (Q3 2023), $149.5 million (Q2 2023), and $125.7 million (Q1 2023).